Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mifepristone and Misoprostol for 2nd Trimester Termination of Pregnancy (13-22 Weeks LMP) in Burkina Faso

NCT03269279 is registered in ClinicalTrials.gov with Gynuity Health Projects as lead sponsor.

NCT NCT03269279
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03269279 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mifepristone and Misoprostol for 2nd Trimester Termination of Pregnancy (13-22 Weeks LMP) in Burkina Faso
Lead sponsor
Gynuity Health Projects
Phase
Phase 3
Overall status
Unknown status
Start date
May 20, 2017
Completion date
December 31, 2019
Enrollment
100 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

medical; abortion, fetus